NIH VideoCast - The IL-23-Th17 Immune Axis: From Bench to Bedside

Skip Navigation

The IL-23-Th17 Immune Axis: From Bench to Bedside

0 seconds of 0 secondsVolume 90%

00:25

00:00

00:00

491 Views

Air date:	Wednesday, October 11, 2017, 4:15:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 491 (86 Live, 405 On-demand)
Category:	Immunology
Runtime:	01:04:58
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Immunonology Interest Group Seminar Following the discovery of IL-23-dependent T cell immunity, the past decade has witnessed a major revision of the T-helper subset paradigm and substantial progress has been made in deciphering the molecular mechanisms of T cell lineage commitment and function. Our recent work focused on the transcriptional control of Th17 cell development, as well as the protective versus pathogenic roles of IL-17 and IL-22 in mucosal tissues. I will discuss the concept of immune ‘counter-regulation’ during organ-specific tissue inflammation. I will also highlight recent clinical data demonstrating that neutralization of IL-17 and IL-23 are remarkably effective for treating immune-mediated inflammatory diseases.

Author:	Dan Cua, Ph.D., Senior Principal Scientist, Immuno-Oncology Discovery, Merck

CIT Live ID:	23454
Permanent link:	https://videocast.nih.gov/watch=23454

Related Videos...